Capital Biosciences Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Capital Biosciences's estimated annual revenue is currently $1.1M per year.(i)
  • Capital Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Capital Biosciences has 7 Employees.(i)
  • Capital Biosciences grew their employee count by 0% last year.

Capital Biosciences's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Capital Biosciences?

Capital Biosciences Inc. is a biotechnology CRO based out of Gaithersburg, Maryland dedicated to connecting researchers from around the world with clinical sites and repositories of high-quality, clinically annotated tissue specimens, as well as custom cell and molecular biology laboratory services. We are committed to fostering global partnerships with the goal of advancing life science research for the benefit of humanity. As the search for new medicines and therapies becomes increasingly paramount, CBI positions itself at the forefront of support for researchers in their efforts to extend and improve the quality of life. CBI has defined and adopted strong bioethics policies and has developed state-of-the-art biospecimen procurement procedures to achieve the highest ethical standards in all of its operations. All donors are protected by anonymity and legal Informed Consent documentation stating usage for medical research purposes and possible benefits to scientific discovery and humanity.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M70%N/A
#2
$0.5M70%N/A
#3
$0.6M8-11%N/A
#4
$0.6M8-27%N/A
#5
$1.7M8-38%N/A